Relative Strength Chart Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 226.83 USD | +0.11% |
|
+2.69% | +13.10% |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
| 07-13 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Other Biotechnology & Medical Research | -0.43% | +2.69% | +13.10% | +26.04% | -42.56% | 10.91B |  | | |
- Stock Market
- Stocks
- CRL Stock
- Charts Charles River Laboratories International, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
